- BESSONNE M, Morel J, Nevers Q, Groutsch J, et al
Inhibition of influenza virus replication by artificial proteins (alphaReps) targeting its RNA-polymerase.
Antiviral Res. 2025 Oct 21:106300. doi: 10.1016/j.antiviral.2025.106300.
PubMed Abstract available - WONG K, Ducharme R, Murphy MSQ, Clarke AE, et al
SARS-CoV-2 infection in pregnancy and infant outcomes in the first year of life: a retrospective cohort study.
BMC Pediatr. 2025;25:842.
PubMed Abstract available - MAGGIO ABR, Palomo S, Joye R, Huguet H, et al
Reduced aerobic capacity in children with multisystem inflammatory syndrome in children (MIS-C) after PICU admission: a retrospective cohort study, 2020-2022.
BMC Pediatr. 2025;25:835.
PubMed Abstract available - HICKMAN HD, Moutsopoulos NM
Don't forget to floss! An innovative approach for vaccine delivery.
Cell. 2025;188:5787-5789.
PubMed Abstract available - GODOY P, Pardos J, Garcia Cenoz M, Parron I, et al
Mask wearing by COVID-19 index cases reduces SARS-CoV-2 transmission to household contacts.
Epidemiol Infect. 2025;153:e125.
PubMed Abstract available - BACSIK DJ, Mills MG, Monroe LD, Spring C, et al
Validation of H5 influenza virus subtyping RT-qPCR assay and low prevalence of H5 detection in 2024-2025 influenza virus season.
J Clin Microbiol. 2025 Oct 21:e0041525. doi: 10.1128/jcm.00415.
PubMed Abstract available - SHIMOTAI Y, Sugawara K, Matsuzaki Y, Muraki Y, et al
Cytoplasmic domain of CM2 is involved in the replication of influenza C virus.
J Gen Virol. 2025;106:002165.
PubMed Abstract available - MOORE CM, Secor EA, Fairbanks-Mahnke A, Everman JL, et al
Independent and interactive effects of viral species on early-life lower respiratory tract illness.
J Infect. 2025 Sep 25:106616. doi: 10.1016/j.jinf.2025.106616.
PubMed Abstract available - RAJAN A, Nagaraj D, Bomidi C, Aloisio GM, et al
Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism.
J Infect. 2025;91:106617.
PubMed Abstract available - GRANVIK C, Persson IL, Barros GWF, Ahlm C, et al
Long-term Physical Capacity Following COVID-19: A Prospective, Three-Year Study.
J Infect. 2025 Sep 12:106614. doi: 10.1016/j.jinf.2025.106614.
PubMed Abstract available - PRITCHARD E, Vihta KD, Lipworth S, Pouwels KB, et al
An Electronic Health Record-Wide Association Study to identify populations at increased risk of E. coli bloodstream infections.
J Infect. 2025 Sep 3:106612. doi: 10.1016/j.jinf.2025.106612.
PubMed Abstract available - JOSEPH R, Marais G, Iranzadeh I, Alisoltani A, et al
Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2.
J Virol. 2025 Sep 5:e0078025. doi: 10.1128/jvi.00780.
PubMed Abstract available - WANG J, Sang X, Zheng W, Chan JF-W, et al
Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main protease.
J Virol. 2025 Sep 15:e0065825. doi: 10.1128/jvi.00658.
PubMed Abstract available - FARRUKEE R, Mordant F, Mackenzie-Kludas C, Mesner D, et al
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.
J Virol. 2025 Sep 15:e0082325. doi: 10.1128/jvi.00823.
PubMed Abstract available - RZYMSKI P, Poniedzialek B, Zarebska-Michaluk D, Tomasiewicz K, et al
High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?
J Virol. 2025;99:e0143225.
PubMed Abstract available - CHIOK KL, Jenik K, Fenton M, Falzarano D, et al
MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures.
J Virol. 2025 Sep 18:e0109825. doi: 10.1128/jvi.01098.
PubMed Abstract available - HAMMER E, Flynn C, Rossler J, Erder J, et al
Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry.
J Virol. 2025 Sep 23:e0118925. doi: 10.1128/jvi.01189.
PubMed Abstract available - TSUJINO S, Tsuda M, Nao N, Okumura K, et al
Evolution of BA.2.86 to JN.1 reveals that functional changes in non-structural viral proteins are required for fitness of SARS-CoV-2.
J Virol. 2025 Sep 23:e0090825. doi: 10.1128/jvi.00908.
PubMed Abstract available - SHU T, Wang X, Li Y, Su J, et al
Respiratory syncytial virus phosphoprotein has NTPase and helicase-like activities.
J Virol. 2025;99:e0099625.
PubMed Abstract available - SUN L, Huang M, Feng S, Zhang W, et al
Developing an eVLP mRNA vaccine for respiratory syncytial virus with enhanced pre-fusion targeting humoral responses.
J Virol. 2025 Sep 30:e0120925. doi: 10.1128/jvi.01209.
PubMed Abstract available - PAN Z, Jiang L, Chen Y, Peng H, et al
Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations.
J Virol. 2025 Oct 3:e0109925. doi: 10.1128/jvi.01099.
PubMed Abstract available - AFZAL M, Willcox MDP, Praet S, Mcdonald M, et al
Evaluating the effectiveness of a novel environmental decontamination system utilizing low-energy hyper-charged photoelectrons against coronavirus.
J Virol Methods. 2026;339:115269.
PubMed Abstract available - HINOJOSA-TRUJILLO D, Dehesa-Canseco F, Garcia-Vega M, Mata-Haro V, et al
Evaluation of two IgG-scFv bispecific antibodies for neutralizing Omicron variants of SARS-CoV-2.
J Virol Methods. 2026;339:115258.
PubMed Abstract available - BRAVI ME, Fuentealba NA, Brasso N, Sguazza GH, et al
Performance evaluation of a SYBR Green-based real-time quantitative PCR for SARS-CoV-2 detection from animal oropharyngeal samples.
J Virol Methods. 2026;339:115259.
PubMed Abstract available - CHEN Y, Zhang T, Zhang J, Dong X, et al
Comparative effects of three SARS-CoV-2 inactivation methods on cytokine detection using LEGENDplex bead-based immunoassays.
J Virol Methods. 2026;339:115244.
PubMed Abstract available
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Stud
Lancet. 2025 Oct 12:S0140-6736(25)01637-X. doi: 10.1016/S0140-6736(25)01637.
PubMed Abstract available
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
Lancet. 2025 Oct 12:S0140-6736(25)01330-3. doi: 10.1016/S0140-6736(25)01330.
PubMed Abstract available- JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis.
Lancet. 2025 Oct 17:S0140-6736(25)01742-8. doi: 10.1016/S0140-6736(25)01742.
PubMed Abstract available - SIEGERS JY, Xie R, Edwards KM, Byrne AMP, et al
Resurgence of Zoonotic Highly Pathogenic Avian Influenza A(H5N1) Virus in Cambodia.
N Engl J Med. 2025;393:1650-1652.
PubMed - CAI M, Xie Y, Al-Aly Z
Association of 2024-2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans.
N Engl J Med. 2025 Oct 8. doi: 10.1056/NEJMoa2510226.
PubMed Abstract available - HEMATRAM YADAV RY, Thangiah N, Bhaskaran KS, Kumarasamy C, et al
Factors associated with hospitalization of people with influenza in a Malaysian tertiary hospital from 2015 to 2019.
PLoS One. 2025;20:e0333921.
PubMed Abstract available - ABIDIN FA, Prathama AG, Fitriana E, Mayangsari A, et al
Depression, anxiety, and stress levels during the COVID-19 pandemic: A longitudinal study among Indonesian psychologists.
PLoS One. 2025;20:e0315584.
PubMed Abstract available - CATALFAMO CJ, Jacobs ET, Falk LP, Lauro P, et al
Concordance between self-reported SARS-CoV-2 positivity and laboratory-confirmed positivity.
PLoS One. 2025;20:e0334102.
PubMed Abstract available - KALIA V, Knauft K
Adults with adverse childhood experiences report greater coronavirus anxiety.
PLoS One. 2025;20:e0323401.
PubMed Abstract available - KUCHLER J, Zinnecker T, Hellwig P, Wolf M, et al
Quantitative analysis of proteomic changes in two monoclonal suspension MDCK cell lines infected with human influenza A virus (H1N1).
PLoS One. 2025;20:e0327939.
PubMed Abstract available - HOLZER A, Stoever A, Lau M, Gleich S, et al
Quantitative and qualitative changes in substance-related administrative offences in road traffic during the SARS-CoV-2 pandemic in Munich.
PLoS One. 2025;20:e0334598.
PubMed Abstract available - BALECH B, Lo Presti A, Telegrafo C, Maisto L, et al
Investigating the evolutionary dynamics and mutational pattern of SARS-CoV-2 spike gene on selected SARS-CoV-2 variants.
PLoS One. 2025;20:e0333093.
PubMed Abstract available - MAKI K
Methodology for predicting hospital admissions and evaluating recovery rates for coronavirus disease in Japan.
PLoS One. 2025;20:e0334643.
PubMed Abstract available - DELAVARY M, Kalantari AH, Farsangi H, Mohammadzadeh Moghaddam A, et al
Effect of COVID-19 restrictions and fuel prices on traffic volume and offenses in Iran: A spatiotemporal analysis.
PLoS One. 2025;20:e0332443.
PubMed Abstract available - FORMIGA RO, Pesenti L, de la Heronniere FC, Ladjemi MZ, et al
Cytosolic proliferating cell nuclear antigen (PCNA) orchestrates neutrophil hyperactivation in COVID-19.
Proc Natl Acad Sci U S A. 2025;122:e2503667122.
PubMed Abstract available - CHAUDHRY T, Tum P, Morrow F, Hargreaves S, et al
Facilitators to strengthening vaccine uptake post-pandemic amongst underserved populations considering social norms and health beliefs: a global systematic review.
Vaccine. 2025;65:127769.
PubMed Abstract available - ZEEVAT F, Luttjeboer J, Korsten K, van Boven M, et al
Evaluating cost-effectiveness of RSV vaccination strategies for older adults in the Netherlands.
Vaccine. 2025;65:127735.
PubMed Abstract available - CAMPBELL PM, Ess GJ, Lale A, Talaat KR, et al
Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews.
Vaccine. 2025;65:127781.
PubMed Abstract available - DOMINGUEZ ISLAS CP, Magaret CA, Molitor C, Serebryannyy L, et al
SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines.
Vaccine. 2025;65:127738.
PubMed Abstract available - OPHIR Y, Wong JH, Haddad KR, Huuskonen A, et al
Expression and characterization of SARS-CoV-2 spike protein in Thermothelomyces heterothallica C1.
Vaccine. 2025;65:127784.
PubMed Abstract available - WROBLEWSKI M, Meler A
Vaccine acceptance and refusal in Western and Central and Eastern European countries: An analysis based on the European Social Survey data from 23 countries, using a classification and regression tree.
Vaccine. 2025;65:127807.
PubMed Abstract available - FANG X, Holding AC, Audet EC, Thai H, et al
Understanding COVID-19 vaccination disparity among Black adults in North America: A two-study motivational approach.
Vaccine. 2025;65:127803.
PubMed Abstract available - OGATA T, Hattori S, Kawachi K, Ishikane M, et al
Durability of effectiveness of a booster dose of COVID-19 bivalent (ancestral/BA.4-5) vaccine against all-cause mortality in older adults in Japan, October 2022 to September 2023.
Vaccine. 2025;65:127796.
PubMed Abstract available - HIRAGA K, Momose H, Kuribayashi W, Uemura M, et al
Development of a novel safety assessment method for quality control of mRNA vaccines based on lung biomarker gene expression.
Vaccine. 2025;65:127805.
PubMed Abstract available - BLADH O, Aguilera K, Sheikh-Mohamed S, Nardulli J, et al
Comparing methods collecting mucosal secretions and detecting SARS-CoV-2 spike IgA in three laboratories across three countries.
Vaccine. 2025;65:127792.
PubMed Abstract available - TSUNEKI-TOKUNAGA A, Komatsu M, Perdana WY, Nishiyama S, et al
Epidemic influenza virus strains with high growth capability induce severe inflammatory response in vivo.
Virology. 2025;613:110717.
PubMed Abstract available
Antiviral Res
No comments:
Post a Comment